Last year, Eli Lilly became the first drug company to begin disclosing its medical education grants on its website. Pfizer is on the verge of implementing similar measures. Meanwhile, most of the 14 other drug and device companies responding to Senator Charles Grassley's recent inquiry on this subject indicate they plan to follow suit in fairly short order. This is widely seen as the beginning of broader efforts on the part of drug and device companies of all sizes to increase transparency of their grants and gifts. This audioconference will feature several leading executives in the forefront of these efforts. It will focus on the operational challenges facing companies, the overall goals of transparency, and the practical implementation of these measures. It will also include important updates on the state and federal legislative initiatives driving this issue.

It is a live event that includes session handouts, an interactive question and answer period, and access for an unlimited number of participants at each call-in site. However, only one site can be offered per registration. It is impermissible for an organization to purchase one registration and to operate multiple sites through an internal telephone system. During the live Audioconference participants will be able to ask questions and make comments. The Audioconference faculty has agreed to take follow-up questions via email. Audioconferences are simple, accessible, cost effective and reach a broad audience locally.

Physicians, Nurses, Pharmacists, Chief Executive Officers, Chief Operating Officers, Chief Information Officers and Chief Financial Officers, Privacy Officials, Security Officers, Compliance Officers, Legal Counsel, Patient Account Managers, Billing Staff and Information Services Staff.

All Faculty Materials will be Posted on the CME Audioconference website: www.CMEAudioconferences.com/CMEAudio20080527 in downloadable PDF Formats.